James Bircher
Chief Operating Officer chez FREELINE THERAPEUTICS HOLDINGS PLC
Profil
James Bircher is currently the Chief Technical Operations Officer at Freeline Therapeutics Holdings Plc since 2021.
Prior to this, he worked as the Head-Quality at Becton, Dickinson & Co. and as the Senior VP-Quality & Technical Operation at Abeona Therapeutics, Inc. He completed his undergraduate degree from Marshall University.
Postes actifs de James Bircher
| Sociétés | Poste | Début |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Operating Officer | 01/07/2021 |
Anciens postes connus de James Bircher
| Sociétés | Poste | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| ABEONA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Formation de James Bircher
| Marshall University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
